Keysary A, Itzhaki A, Rubinstein E, Oron C, Keren G
Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel.
J Antimicrob Chemother. 1996 Oct;38(4):727-31. doi: 10.1093/jac/38.4.727.
The anti-rickettsial activity of azithromycin and clarithromycin was studied in Vero cells. The rate of rickettsial inhibition-growth caused by both macrolides was determined using rickettsial counts and ELISA. Both macrolides inhibited > 50% the growth of Rickettsia conorii and Rickettsia typhi at concentrations of 1.0 and 0.1 mg/L, respectively. The growth of Coxiella burnetii was inhibited to a rate of > or = 50% at the concentrations of 0.01 and 1.0 mg/L of azithromycin and clarithromycin, respectively.
在Vero细胞中研究了阿奇霉素和克拉霉素的抗立克次体活性。使用立克次体计数和酶联免疫吸附测定法(ELISA)确定了两种大环内酯类药物引起的立克次体生长抑制率。两种大环内酯类药物分别在浓度为1.0和0.1mg/L时,对康氏立克次体和伤寒立克次体的生长抑制率均>50%。阿奇霉素和克拉霉素分别在浓度为0.01和1.0mg/L时,对贝氏柯克斯体的生长抑制率≥50%。